Junge W, Heger-Mahn D, Trummer D, Merz M.

Investigation of the Hemostatic Effect of a Transdermal Patch Containing 0.55mg Ethinyl Estradiol and 2.1mg Gestodene Compared with a Monophasis Oral Contraceptive Containing 0.03mg Ethinyl EStardiol and 0.15mg Levonogestrel: An Open-Label, Randomized, Crossover Study.
Drugs R D. 2013 Sep; 13(3):223-33.

Fraser IS, Zeun S, Wilke B, Junge W, Serrani M.

Improving the objective quality of large-scale clinical trials for women with heavy menstrual bleeding: experience from 2 multi-center, randomized trials.
Reprod Sci. 2013 Jul;20(7):745-54. 

Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W.
Hemostatic effects of a novel estradiol-based oral contraceptive: An open-label randomized, crossover study of estardiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Drugs R D. 2011; 11(2):159-70.

Junge W, Troge B, Klein G, Poppe W, Gerber M.
Evaluation of a new assay for pancreatic amylase: performance characteristics and estimation of reference intervals.
Clin Biochem. 1989 Apr;22(2):109-14.

Junge W, Wilke B, Halabi A, Klein G.

Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffe method.

Clin Chim Acta. 2004 Jun;344(1-2):137-48.

Junge W, Wortmann W, Wilke B, Waldenstrom J, Kurrle-Weittenhiller A, Finke J, Klein G.

Development and evaluation of assays for the determination of total and pancreatic amylase at 37 degrees C according to the principle recommended by the IFCC.

Clin Biochem. 2001 Nov;34(8):607-15. Erratum in: Clin Biochem. 2003 Mar;36(3):161.

Meier M, Wilke B, Junge W.

[Determination of beta-N-acetylglucosaminidase and albumin in urine: comparison of methods and effect of gel filtration in human and rat urine]

Wien Klin Wochenschr Suppl. 1991;189:44-7. German.

Heine H, El-Samalouti VT, Notzel C, Pfeiffer A, Lentschat A, Kusumoto S, Schmitz G, Hamann L, Ulmer AJ.

CD55/decay accelerating factor is part of the lipopolysaccharide-induced receptor complex.

Eur J Immunol. 2003 May;33(5):1399-408.

Heine H, Ulmer AJ, El-Samalouti VT, Lentschat A, Hamann L.

Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex.

J Endotoxin Res. 2001;7(3):227-31.

Muhvic D, El-Samalouti V, Flad HD, Radosevic-Stasic B, Rukavina D.

The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers.

Mediators Inflamm. 2001 Jun;10(3):155-62.

El-Samalouti VT, Hamann L, Flad HD, Ulmer AJ.

The biology of endotoxin.

Methods Mol Biol. 2000;145:287-309. Review.

Lentschat A, El-Samalouti VT, Schletter J, Kusumoto S, Brade L, Rietschel ET, Gerdes J, Ernst M, Flad H, Ulmer AJ.

The internalization time course of a given lipopolysaccharide chemotype does not correspond to its activation kinetics in monocytes.

Infect Immun. 1999 May;67(5):2515-21.

El-Samalouti VT, Schletter J, Chyla I, Lentschat A, Mamat U, Brade L, Flad HD, Ulmer AJ, Hamann L.

Identification of the 80-kDa LPS-binding protein (LMP80) as decay-accelerating factor (DAF, CD55).

FEMS Immunol Med Microbiol. 1999 Mar;23(3):259-69.

Hamann L, El-Samalouti V, Ulmer AJ, Flad HD, Rietschel ET.

Components of gut bacteria as immunomodulators.

Int J Food Microbiol. 1998 May 26;41(2):141-54. Review.

Rietschel ET, Schletter J, Weidemann B, El-Samalouti V, Mattern T, Zahringer U, Seydel U, Brade H, Flad HD, Kusumoto S, Gupta D, Dziarski R, Ulmer AJ.

Lipopolysaccharide and peptidoglycan: CD14-dependent bacterial inducers of inflammation.

Microb Drug Resist. 1998 Spring;4(1):37-44. Review.

El-Samalouti VT, Schletter J, Brade H, Brade L, Kusumoto S, Rietschel ET, Flad HD, Ulmer AJ.

Detection of lipopolysaccharide (LPS)-binding membrane proteins by immuno-coprecipitation with LPS and anti-LPS antibodies.

Eur J Biochem. 1997 Dec 1;250(2):418-24.

Kleeberg I, Welzel K, Vandenheuvel J, Muller RJ, Deckwer WD.

Characterization of a new extracellular hydrolase from Thermobifida fusca degrading aliphatic-aromatic copolyesters.

Biomacromolecules. 2005 Jan-Feb;6(1):262-70.

Gouda MK, Kleeberg I, van den Heuvel J, Muller RJ, Deckwer WD.

Production of a polyester degrading extracellular hydrolase from Thermomonospora fusca.

Biotechnol Prog. 2002 Sep-Oct;18(5):927-34.

Witt U, Einig T, Yamamoto M, Kleeberg I, Deckwer WD, Muller RJ.

Biodegradation of aliphatic-aromatic copolyesters: evaluation of the final biodegradability and ecotoxicological impact of degradation intermediates.

Chemosphere. 2001 Jul;44(2):289-99.

Muller RJ, Kleeberg I, Deckwer WD.

Biodegradation of polyesters containing aromatic constituents.

J Biotechnol. 2001 Mar 30;86(2):87-95. Review.

Kleeberg I, Hetz C, Kroppenstedt RM, Muller RJ, Deckwer WD.

Biodegradation of aliphatic-aromatic copolyesters by Thermomonospora fusca and other thermophilic compost isolates.

Appl Environ Microbiol. 1998 May;64(5):1731-5.

Knuchel R, Buttner R, Kleeberg I, Masters JR, Hofstadter F.

[Three dimensional cell culture in vitro for the analysis of proliferation and differentiation of urinary bladder carcinoma]

Verh Dtsch Ges Pathol. 1988;72:227-8. German.

Schoenicke G, Diamant R, Donner A, Roehrborn A, Grabensee B, Plum J.

Histochemical distribution and expression of aquaporin 1 in the peritoneum of patients undergoing peritoneal dialysis: relation to peritoneal transport.

Am J Kidney Dis. 2004 Jul;44(1):146-54.

Schoenicke G, Grabensee B, Plum J.

Dialysis with icodextrin interferes with measurement of serum alpha-amylase activity.

Nephrol Dial Transplant. 2002 Nov;17(11):1988-92.

Plum J, Hermann S, Fussholler A, Schoenicke G, Donner A, Rohrborn A, Grabensee B.

Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties.

Kidney Int Suppl. 2001 Feb;78:S42-7.

Plum J, Schoenicke G, Grabensee B.

Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.

Am J Kidney Dis. 1997 Sep;30(3):413-22.

Plum J, Fussholler A, Schoenicke G, Busch T, Erren C, Fieseler C, Kirchgessner J, Passlick-Deetjen J, Grabensee B.

In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.

Nephrol Dial Transplant. 1997 Aug;12(8):1652-60.